Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Akynzeo and dexamethasone for CINV in cervical cancer
NCT03668639Phase 3Unknown
- Start
- Sep 2018
- Primary completion
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of palonosetron in chemotherapy-induced nausea and vomiting (CINV) and radiotherapy-induced nausea and vomiting (RINV). Status: unknown.
02
Drugs
palonosetron
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)radiotherapy-induced nausea and vomiting (RINV)
Beyond the preview
Go deeper on NCT03668639.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03668639.